Chinese medicine is important and irreplaceable in China's pharmaceutical industry. It  has been included in the national strategic emerging industries. Shen Mai Injection is one of the best sold Chinese medicine. In order to enhance the technical level of Shen Mai Injection, research team of Professor Cheng Yiyu of Zhejiang University together with Chia Tai Qingchunbao, Pharmaceutical Co., Ltd. joint commitment to the national scientific and technological project in the Ninth Five-Year Plan. The achievements have won the 2004 National Science and Technology Progress Second Award. Shen Mai Injection technology innovation research for eight years has made a series of major achievements.

November 18th, in Zhejiang University, Shenmai injection technology quality control systems engineering achievements appraisal meeting organized. Chinese Academy academician Yang Shengli, Zhang Boli, Wang Hongyang, Hou Huimin, and Liu Changxiao were the Committee of Experts.

The identification of the Committee reviewed the detailed technical data, listened to work reports the effects of industrial production site, and questions on relevant issues to the research group. This achievements were obtained in cooperation of Zhejiang University, China Food and Drugs Inspection Institute, Tianjin University of Traditional Chinese Medicine and Chia Tai Qingchunbao Pharmaceutical Co., Ltd. Identification Committee believes that the results significantly enhance the Chinese medicine pharmaceutical process quality and improve drug safety. It is a major scientific and technological progress of the Chinese pharmaceutical engineering field, with a demonstration of traditional Chinese medicine pharmaceutical Industry.